Coronary microvasculopathy after heart transplantation: A new marker to guide future trials?

Circulation

Volumn 116, Issue 11, 2007, Pages 1224-1225

  Miller, Leslie W ^a,b  

^a GEORGETOWN UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

Atherosclerosis; Editorials; Prognosis; Transplantation

Indexed keywords

ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; EDITORIAL; ENDOTHELIUM INJURY; HEART TRANSPLANTATION; HUMAN; MICROANGIOPATHY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SURVIVAL;

BIOLOGICAL MARKERS; CLINICAL TRIALS; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; HEART TRANSPLANTATION; HUMANS; MICROCIRCULATION;

EID: 34948896936     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.728386     Document Type: Editorial

References (15)

1. Lietz KL, Miller LW. Current understanding and management of allograft vasculopathy. Semin Thorac Cardiovasc Surg. 2004;16:386-394.
2. Miller LW. Allograft coronary disease: the role of antigen independent mechanisms in pathogenesis. Ann Transplant. 1997;2:61-64.
3. Shoskes DA, Parfrey NA, Halloran PF. Increased major histocompatibility complex antigen expression in unilateral ischemic acute tubular necrosis in the mouse. Transplantation. 1990;49:201-207.
4. Davis SF, Yeung AC, Meredith IT, Charbonneau F, Ganz P, Selwyn AP, Anderson TJ. Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year posttransplant. Circulation. 1996;93:457-462.
5. Lenstrom K, Koskinen P, Krogerus L, Bruggeman C, Hayry P. Cytomegalovirus antigen expression, endothelial cell proliferation and intimal thickening in rat cardiac allografts after cytomegalovirus infection. Circulation. 1993;92:2594-2604.
6. Valentine H, Rickenbacher P, Kemna M, Hunt S, Chen YD, Reaven G, Stinson EB. Metabolic abnormalities characteristic of dysmetabolic syndrome predict the development of transplant coronary artery disease. Circulation. 2001;103:2144-2152.
7. Gao HZ, Hunt SA, Alderman EH, Liang D, Yeung AC, Schroeder JS. Relationship of donor age and pre-existing coronary disease on angiography and IVUS to later development of accelerated allograft coronary artery disease. J Am Coll Cardiol. 1997;29:623-629.
8. Kobashigawa JA, Weiner L, Johnson J, Currier JW, Yeatman L, Cassem J, Tobis J. Longitudinal study of vascular remodeling in coronary artery disease after heart transplantation. J Heart Lung Transplant. 2000;19:546-550.
9. Palmer DC, Roodman ST, Miller LW, Sarafian J, McBride L, Pennington DG. Heart graft atherosclerosis: an ominous finding on endomyocardial biopsy. Transplantation. 1985;39:385-389.
10. Hiemann NE, Wellnhofer E, Knosalla C, Lehmkuhl HB, Stein J, Hetzer R, Meyer R. Prognostic impact of microvasculopathy on survival after heart transplantation: evidence from 9713 endomyocardial biopsies. Circulation. 2007;116:1274-1282.
11. Mehra MR. Contemporary concepts in prevention and treatment of cardiac allograft vasculopathy. Am J Transplant. 2006;6:1248-1256.
12. Waters DD, Guyton JR, Herrington DM, McGowan MP, Wenger NK, Shear C. Treating to New Targets (TNT) Study: does lowering low-density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit? Am J Cardiol. 2004;93:154-158.
13. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk W, Knudtson M, Dada M, Casperson P, Harris CL, Spertus JA, Shaw L, Chaitman BR, Mancini GB, Berman DS, Gau G, Weintraub WS, for the COURAGE Trial Coprincipal Investigators and Study Coordinators. The evolving pattern of symptomatic coronary artery disease in the United States and Canada: baseline characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial. Am J Cardiol. 2007;99:208-212.
14. Reinsmoen NL, Jackson AM, DeOliveira A, Matas AJ, Gillingham K, Ward FE. Cellular immunology markers postransplantation predictive of long-term graft outcome. Ann Transplant. 2000;5:50-60.
15. Miller LW, Dai E, Nash P, Liu L, Icton C, Klironomos D, Fan L, Nation PN, Zhong R, McFadden G, Lucas A. Inhibition of transplant vasculopathy in a rat aortic allograft model after infusion of anti-inflammatory viral serpins. Circulation. 2000;101:1598-1605.